(19)
(11) EP 1 616 024 A1

(12)

(43) Date of publication:
18.01.2006 Bulletin 2006/03

(21) Application number: 04726162.3

(22) Date of filing: 07.04.2004
(51) International Patent Classification (IPC): 
C12Q 1/34(1980.01)
C12N 9/16(1980.01)
A61K 38/00(1995.01)
A61P 9/00(2000.01)
 C07K 16/40(1995.01)
A61K 31/00(1985.01)
A61K 39/00(1985.01)
(86) International application number:
PCT/EP2004/003739
(87) International publication number:
WO 2004/090157 (21.10.2004 Gazette 2004/43)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL HR LT LV MK

(30) Priority: 10.04.2003 EP 03007993

(71) Applicants:
  • F. HOFFMANN-LA ROCHE AG
    4070 Basel (CH)
  • Decode Genetics EHF.
    101 Reykjavik (IS)

(72) Inventors:
  • EVERS, Stefan
    79379 Muellheim (DE)
  • FINGERLE, Juergen
    79400 Kandern (DE)
  • HIMBER, Jacques
    F-68500 Guebwiller (FR)
  • GRETARSDOTTIR, Solveig
    101 Reykjavik (IS)
  • GULCHER, Jeffrey, R.
    Lake Barrington, IL 60010 (IS)

(74) Representative: Witte, Hubert et al
Grenzacherstrasse, 124
4070 Basel
4070 Basel (CH)

   


(54) THE USE OF PDE4D IN THE SCREENING FOR MEDICAMENTS AGAINST ATHEROSCLEROSIS